Use of a Permanent Magnetic Field to Inhibit the Development of Canine Osteoarthritis

Richard A. Rogachefsky, Roy D Altman, Marko S. Markov, Herman S Cheung

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

This study was designed to determine the potential of a permanent magnetic field to inhibit the progression of osteoarthritis (OA) in a canine model. The magnetic field was created by 72 dominosized ceramic magnets with surface field strength of 1100 G (0.11 T). The magnetic field strength at the surface of the mattress was 450-500 G (45-50 mT) and was equally distributed over the mattress surface. Eighteen animals had closed resection of their right stifle anterior cruciate ligament. Their kennel floors were covered in one of three ways: no floor mattress (OA) (N = 6); a floor mattress with domino-sized ceramic pieces placed between two layers of foam (sham control OA-MAT) (N = 6); or a floor mattress with domino-sized ceramic permanent magnets placed between two layers of foam (OA-MAT-MAG) (N = 6). Animals were kept in their cages except for 4 h of exercise each day. The left stifle of six animals served as the normal control. The stifle joints were examined at 12 weeks for synovial effusion, gross anatomic appearance, microscopic anatomic appearance (Mankin score), and metalloproteinase (MMP)-1 and -3. Macroscopically, the OA-MAT-MAG group appeared to have less synovitis, less synovial effusion, less disruption of the cartilage surface, and less cartilage ulceration than did the OA group or the control mattress group. The mean Mankin score for the OA-MAT-MAG group was less than that for the OA group (4.2 ± 0.8 vs. 6.7 ± 0.3; P < .05) and the control mattress group (4.2 ± 0.8 vs. 5.2 ± 0.8; P > .05), but greater than that for the normal left group (4.2 ± 0.8 vs. 1.0 ± 0.4; P < .05). These scores show a trend of improvement for OA-MAT-MAG group but the difference with the sham control OA-MAT group was not statistically significant. In immunohistochemical studies, the OA-MAT-MAG group cartilage was stained less heavily for MMP-1 and MMP-3 than were the OA group cartilage and the control mattress group cartilage, but did not differ significantly in MMP-1 and MMP-3 from the normal left group cartilage. The OA-MAT-MAG group did not differ from the normal left group in MMP-3 as determined by Western blot analysis. The study suggests that OA of the medial femoral condyle developed in a canine model exposed to a magnetic field may be inhibited beyond the benefit provided by mattress. Further studies are needed to delineate more precisely the effect of the magnetic field in reducing the severity of OA.

Original languageEnglish
Pages (from-to)260-270
Number of pages11
JournalBioelectromagnetics
Volume25
Issue number4
DOIs
StatePublished - May 1 2004

Fingerprint

osteoarthritis
Magnetic Fields
magnetic fields
Osteoarthritis
Canidae
dogs
Metalloproteases
metalloproteinases
cartilage
Cartilage
Stifle
ceramics
Ceramics
Magnets
foams
anterior cruciate ligament
synovitis
animals
Control Groups
Synovitis

Keywords

  • Cartilage
  • Degeneration
  • Enzymes
  • Magnetic mattress
  • Osteoarthritis
  • Static magnetic fields

ASJC Scopus subject areas

  • Agricultural and Biological Sciences (miscellaneous)
  • Biophysics

Cite this

Use of a Permanent Magnetic Field to Inhibit the Development of Canine Osteoarthritis. / Rogachefsky, Richard A.; Altman, Roy D; Markov, Marko S.; Cheung, Herman S.

In: Bioelectromagnetics, Vol. 25, No. 4, 01.05.2004, p. 260-270.

Research output: Contribution to journalArticle

Rogachefsky, Richard A. ; Altman, Roy D ; Markov, Marko S. ; Cheung, Herman S. / Use of a Permanent Magnetic Field to Inhibit the Development of Canine Osteoarthritis. In: Bioelectromagnetics. 2004 ; Vol. 25, No. 4. pp. 260-270.
@article{020efe2003ea44cfa11de86d41006a5b,
title = "Use of a Permanent Magnetic Field to Inhibit the Development of Canine Osteoarthritis",
abstract = "This study was designed to determine the potential of a permanent magnetic field to inhibit the progression of osteoarthritis (OA) in a canine model. The magnetic field was created by 72 dominosized ceramic magnets with surface field strength of 1100 G (0.11 T). The magnetic field strength at the surface of the mattress was 450-500 G (45-50 mT) and was equally distributed over the mattress surface. Eighteen animals had closed resection of their right stifle anterior cruciate ligament. Their kennel floors were covered in one of three ways: no floor mattress (OA) (N = 6); a floor mattress with domino-sized ceramic pieces placed between two layers of foam (sham control OA-MAT) (N = 6); or a floor mattress with domino-sized ceramic permanent magnets placed between two layers of foam (OA-MAT-MAG) (N = 6). Animals were kept in their cages except for 4 h of exercise each day. The left stifle of six animals served as the normal control. The stifle joints were examined at 12 weeks for synovial effusion, gross anatomic appearance, microscopic anatomic appearance (Mankin score), and metalloproteinase (MMP)-1 and -3. Macroscopically, the OA-MAT-MAG group appeared to have less synovitis, less synovial effusion, less disruption of the cartilage surface, and less cartilage ulceration than did the OA group or the control mattress group. The mean Mankin score for the OA-MAT-MAG group was less than that for the OA group (4.2 ± 0.8 vs. 6.7 ± 0.3; P < .05) and the control mattress group (4.2 ± 0.8 vs. 5.2 ± 0.8; P > .05), but greater than that for the normal left group (4.2 ± 0.8 vs. 1.0 ± 0.4; P < .05). These scores show a trend of improvement for OA-MAT-MAG group but the difference with the sham control OA-MAT group was not statistically significant. In immunohistochemical studies, the OA-MAT-MAG group cartilage was stained less heavily for MMP-1 and MMP-3 than were the OA group cartilage and the control mattress group cartilage, but did not differ significantly in MMP-1 and MMP-3 from the normal left group cartilage. The OA-MAT-MAG group did not differ from the normal left group in MMP-3 as determined by Western blot analysis. The study suggests that OA of the medial femoral condyle developed in a canine model exposed to a magnetic field may be inhibited beyond the benefit provided by mattress. Further studies are needed to delineate more precisely the effect of the magnetic field in reducing the severity of OA.",
keywords = "Cartilage, Degeneration, Enzymes, Magnetic mattress, Osteoarthritis, Static magnetic fields",
author = "Rogachefsky, {Richard A.} and Altman, {Roy D} and Markov, {Marko S.} and Cheung, {Herman S}",
year = "2004",
month = "5",
day = "1",
doi = "10.1002/bem.10192",
language = "English",
volume = "25",
pages = "260--270",
journal = "Bioelectromagnetics",
issn = "0197-8462",
publisher = "Wiley-Liss Inc.",
number = "4",

}

TY - JOUR

T1 - Use of a Permanent Magnetic Field to Inhibit the Development of Canine Osteoarthritis

AU - Rogachefsky, Richard A.

AU - Altman, Roy D

AU - Markov, Marko S.

AU - Cheung, Herman S

PY - 2004/5/1

Y1 - 2004/5/1

N2 - This study was designed to determine the potential of a permanent magnetic field to inhibit the progression of osteoarthritis (OA) in a canine model. The magnetic field was created by 72 dominosized ceramic magnets with surface field strength of 1100 G (0.11 T). The magnetic field strength at the surface of the mattress was 450-500 G (45-50 mT) and was equally distributed over the mattress surface. Eighteen animals had closed resection of their right stifle anterior cruciate ligament. Their kennel floors were covered in one of three ways: no floor mattress (OA) (N = 6); a floor mattress with domino-sized ceramic pieces placed between two layers of foam (sham control OA-MAT) (N = 6); or a floor mattress with domino-sized ceramic permanent magnets placed between two layers of foam (OA-MAT-MAG) (N = 6). Animals were kept in their cages except for 4 h of exercise each day. The left stifle of six animals served as the normal control. The stifle joints were examined at 12 weeks for synovial effusion, gross anatomic appearance, microscopic anatomic appearance (Mankin score), and metalloproteinase (MMP)-1 and -3. Macroscopically, the OA-MAT-MAG group appeared to have less synovitis, less synovial effusion, less disruption of the cartilage surface, and less cartilage ulceration than did the OA group or the control mattress group. The mean Mankin score for the OA-MAT-MAG group was less than that for the OA group (4.2 ± 0.8 vs. 6.7 ± 0.3; P < .05) and the control mattress group (4.2 ± 0.8 vs. 5.2 ± 0.8; P > .05), but greater than that for the normal left group (4.2 ± 0.8 vs. 1.0 ± 0.4; P < .05). These scores show a trend of improvement for OA-MAT-MAG group but the difference with the sham control OA-MAT group was not statistically significant. In immunohistochemical studies, the OA-MAT-MAG group cartilage was stained less heavily for MMP-1 and MMP-3 than were the OA group cartilage and the control mattress group cartilage, but did not differ significantly in MMP-1 and MMP-3 from the normal left group cartilage. The OA-MAT-MAG group did not differ from the normal left group in MMP-3 as determined by Western blot analysis. The study suggests that OA of the medial femoral condyle developed in a canine model exposed to a magnetic field may be inhibited beyond the benefit provided by mattress. Further studies are needed to delineate more precisely the effect of the magnetic field in reducing the severity of OA.

AB - This study was designed to determine the potential of a permanent magnetic field to inhibit the progression of osteoarthritis (OA) in a canine model. The magnetic field was created by 72 dominosized ceramic magnets with surface field strength of 1100 G (0.11 T). The magnetic field strength at the surface of the mattress was 450-500 G (45-50 mT) and was equally distributed over the mattress surface. Eighteen animals had closed resection of their right stifle anterior cruciate ligament. Their kennel floors were covered in one of three ways: no floor mattress (OA) (N = 6); a floor mattress with domino-sized ceramic pieces placed between two layers of foam (sham control OA-MAT) (N = 6); or a floor mattress with domino-sized ceramic permanent magnets placed between two layers of foam (OA-MAT-MAG) (N = 6). Animals were kept in their cages except for 4 h of exercise each day. The left stifle of six animals served as the normal control. The stifle joints were examined at 12 weeks for synovial effusion, gross anatomic appearance, microscopic anatomic appearance (Mankin score), and metalloproteinase (MMP)-1 and -3. Macroscopically, the OA-MAT-MAG group appeared to have less synovitis, less synovial effusion, less disruption of the cartilage surface, and less cartilage ulceration than did the OA group or the control mattress group. The mean Mankin score for the OA-MAT-MAG group was less than that for the OA group (4.2 ± 0.8 vs. 6.7 ± 0.3; P < .05) and the control mattress group (4.2 ± 0.8 vs. 5.2 ± 0.8; P > .05), but greater than that for the normal left group (4.2 ± 0.8 vs. 1.0 ± 0.4; P < .05). These scores show a trend of improvement for OA-MAT-MAG group but the difference with the sham control OA-MAT group was not statistically significant. In immunohistochemical studies, the OA-MAT-MAG group cartilage was stained less heavily for MMP-1 and MMP-3 than were the OA group cartilage and the control mattress group cartilage, but did not differ significantly in MMP-1 and MMP-3 from the normal left group cartilage. The OA-MAT-MAG group did not differ from the normal left group in MMP-3 as determined by Western blot analysis. The study suggests that OA of the medial femoral condyle developed in a canine model exposed to a magnetic field may be inhibited beyond the benefit provided by mattress. Further studies are needed to delineate more precisely the effect of the magnetic field in reducing the severity of OA.

KW - Cartilage

KW - Degeneration

KW - Enzymes

KW - Magnetic mattress

KW - Osteoarthritis

KW - Static magnetic fields

UR - http://www.scopus.com/inward/record.url?scp=2342565651&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=2342565651&partnerID=8YFLogxK

U2 - 10.1002/bem.10192

DO - 10.1002/bem.10192

M3 - Article

C2 - 15114635

AN - SCOPUS:2342565651

VL - 25

SP - 260

EP - 270

JO - Bioelectromagnetics

JF - Bioelectromagnetics

SN - 0197-8462

IS - 4

ER -